Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Amarantus Bioscience Holdings (AMBS) Message Board

Those who are now complaining about dilution a

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 30065
Posted On: 04/11/2015 2:21:52 AM
Avatar
Posted By: Warp
Re: Sidepocket #19325


Those who are now complaining about dilution and issuing shares to fund the recent acquisitions clearly didn't do their homework. Gerald told us verbally and in print his plans for the increase in authorized shares. Some only heard or saw what they wanted to hear or see.
Quote:
As of this date, however, the Company requires additional authorized shares to assure the capital markets and investors that the Company has adequate common shares available to complete M&A activity if an attractive opportunity presents itself, raise additional funds if needed, and offer adequate equity compensation to enable recruitment of the best talent the Company will be seeking to bring on full-time as employees. The Company has been advised by various stakeholders in the larger capital markets community that it is best for the Company to achieve an appropriate capital structure while still on the OTC Markets so that the cap structure risk is mitigated once on a national exchange. In addition to an increase in the number of our authorized shares, we are seeking shareholder approval for various other matters that will better position the Company for the up-list to a national exchange.

http://www.thechairmansblog.com/amarantus-bio...-strategy/

He also described these goals in the Sept. 2014 business update call in response to a question posed by JPetro. Some act as if the use of shares in the ensuing acquisitions was somehow counter to what was previously claimed. Hogwash. I realize the company was looking for non-dilutive means as preferable options, but they clearly described the need for additional shares to include acquisitions.


(0)
(0)




Amarantus Bioscience Holdings (AMBS) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us